STOCK TITAN

Alkermes to Participate in the Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) announced participation in a fireside chat at the Jefferies Healthcare Conference on June 8, 2022, at 2:30 p.m. ET. The event will be accessible via live webcast on Alkermes' website and archived for 14 days. Alkermes is a global biopharmaceutical firm focused on innovative treatments for conditions like alcohol and opioid dependence, schizophrenia, and bipolar I disorder. Headquartered in Dublin, Ireland, the company also has facilities in Massachusetts, Ohio, and Ireland.

Positive
  • None.
Negative
  • None.

DUBLIN, June 1, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 2:30 p.m. ET (7:30 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-jefferies-healthcare-conference-301558669.html

SOURCE Alkermes plc

FAQ

When is Alkermes participating in the Jefferies Healthcare Conference?

Alkermes will participate in the Jefferies Healthcare Conference on June 8, 2022, at 2:30 p.m. ET.

How can I access the Alkermes conference webcast?

The Alkermes conference webcast can be accessed on their website under the Investors tab.

What time is the Alkermes presentation at the Jefferies Healthcare Conference?

The Alkermes presentation is scheduled for 2:30 p.m. ET.

How long will the Alkermes presentation be available for viewing?

The presentation will be archived for 14 days after the live event.

Where is Alkermes headquartered?

Alkermes is headquartered in Dublin, Ireland.

What areas does Alkermes focus on in its product development?

Alkermes focuses on developing medicines for neuroscience and oncology, including treatments for alcohol dependence and schizophrenia.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.77B
169.22M
1.33%
113.13%
9.78%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN 4